Basic Information Experimental Physicochemical Property Pharmacokinetic/Toxicokinetic Property Maximum Dosage Drug Property Radar Chart

Basic Information

Drug ID DDPD01248 ...
Drug Name Docetaxel
Molecular Weight 807.8792
Molecular Formula C43H53NO14
CAS Number 114977-28-5
SMILES [H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
External Links
DRUGBANK DB01248
T3DB T3D3501
PubChem Compound 148124
PDR 2562
Drugs.com Drugs.com Drug Page

Experimental Physicochemical Property

Property Name Property Value Unit Raw Value Raw Unit Reference
Log P 2.4 - 2.4 - DRUGBANK
Melting Point 232.0 ℃ 232 ℃ PhysProp

Pharmacokinetic/ Toxicokinetic Property

Property Name Property Value Unit Raw Value Raw Unit Annotation Factor Reference
C Max 2400.0 ng/ml 2.4±0.9 mcg/ml intravenous infusion, IV in drop; tumor; The Pharmacological Basis of Therapeutics
Clearance 21.0 L/h/m2 21.0 L/h/m2 Total clearance; intravenous injection, IV; tumor; patients; DRUGBANK
Clearance 22.6 L/h/m2 22.6±7.7 L/h/m2 mild hepatic impairment ↓ ;moderate hepatic impairment ↓ ; The Pharmacological Basis of Therapeutics
Clearance 0.84 L/h/kg 14 ml/min/kg intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Volume of Distribution 113.0 L 113.0 L DRUGBANK
Volume of Distribution 72.0 L/m2 72±24 L/m2 The Pharmacological Basis of Therapeutics
Volume of Distribution 2.1 L/kg 2.1 L/kg intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Half-life 0.0667 h 4 min distribution half-life; DRUGBANK
Half-life 0.60 h 36 min elimination half-life; DRUGBANK
Half-life 11.1 h 11.1 h terminal half-life; DRUGBANK
Half-life 13.6 h 13.6±6.1 h Male, men;  Female, women; tumor; The Pharmacological Basis of Therapeutics
Half-life 11.0 h 11 h intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Toxicity LD50 2000.0 mg/kg >2000 mg/kg PO, oral; Rattus, Rat; DRUGBANK
Toxicity LD50 2000.0 mg/kg >2000 mg/kg PO, oral; Rattus, Rat; T3DB
Eliminate Route 6.0 % 6 % Urinary excretion; DRUGBANK
Eliminate Route 75.0 % 75 % Faeces excretion; DRUGBANK
Eliminate Route 2.1 % 2.1±0.2 % Urinary excretion; tumor; human, homo sapiens; Unchanged drug; The Pharmacological Basis of Therapeutics
Protein Binding 97.0 % 97 % plasma proteins; tumor; DRUGBANK
Protein Binding 94.0 % 94 % tumor; human, homo sapiens; The Pharmacological Basis of Therapeutics

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Frequency Brand Name Component Reference
Max dose for children 65.0 mg/m2 65 mg/m2 intravenous injection, IV q3w Docefrez docetaxel PDR
Max dose for children 125.0 mg/m2 125 mg/m2 intravenous injection, IV Docefrez docetaxel PDR
Max dose for adolescents 100.0 mg/m2 100 mg/m2 intravenous injection, IV; over 1 hour every 3 weeks Docefrez docetaxel PDR
Max dose for adolescents 40.0 mg/m2 40 mg/m2 qw Docefrez docetaxel PDR
Max dose for adolescents 100.0 mg/m2 100 mg/m2 Intraperitoneal, IP q3w Docefrez docetaxel PDR
Max dose for elderly 100.0 mg/m2 100 mg/m2 intravenous injection, IV; over 1 hour every 3 weeks Docefrez docetaxel PDR
Max dose for elderly 40.0 mg/m2 40 mg/m2 qw Docefrez docetaxel PDR
Max dose for elderly 100.0 mg/m2 100 mg/m2 Intraperitoneal, IP q3w Docefrez docetaxel PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1